IEFQ:LSE:LSE-iShares Edge MSCIope Quality Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 900.3

Change

+5.90 (+0.66)%

Market Cap

USD 0.49B

Volume

6.32K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.95 (+1.53%)

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

+196.00 (+2.40%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

-121.00 (-1.43%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

+6.75 (+3.73%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.15 (-1.10%)

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.17 (-0.99%)

USD 636.40B
0R1I:LSE NVIDIA Corp.

-2.75 (-0.29%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-20.00 (-0.99%)

USD 330.91B
0QZK:LSE Coca-Cola Co.

+0.25 (+0.40%)

USD 266.08B

ETFs Containing IEFQ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.21% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.21% 54% F 56% F
Trailing 12 Months  
Capital Gain 10.90% 50% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.90% 49% F 57% F
Trailing 5 Years  
Capital Gain 59.53% 69% C- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.53% 67% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 8.49% 66% D+ 69% C-
Dividend Return 8.49% 66% D+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.76% 64% D 78% C+
Risk Adjusted Return 78.93% 90% A- 93% A
Market Capitalization 0.49B 70% C- 60% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike